Vida Health, a value-based, virtual cardiometabolic provider that enables patients to manage metabolic instability, today announced its Metabolic Control Framework, a new, clinically grounded approach ...
Researchers in Germany recently evaluated executive functions in 36 patients who were diagnosed with PKU during childhood. Significant negative correlations were observed between elevated childhood ...
Researchers discovered that the liver hormone FGF21 signals hindbrain neurons to control appetite and metabolism during ...
MASLD is one of the pressing public health issues; yet, unfortunately, there is a scarcity of available pharmacological management options. GLP-1RAs have transformed the treatment landscape for ...
Metabolic diseases, including type 2 diabetes (T2D), obesity, and metabolic syndrome, are a growing threat to global public health. More than 537 million adults currently live with T2D, and this ...
GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...
The clinically grounded framework replaces fragmented programs with coordinated, acuity-based care to improve outcomes and reduce healthcare spend Vida Health, a value-based, virtual cardiometabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results